Single-cell RNA-seq with spike-in cells enables accurate quantification of cell-specific drug effects in pancreatic islets
Year: 2020
Type: article
Abstract: BACKGROUND: Single-cell RNA-seq (scRNA-seq) is emerging as a powerful tool to dissect cell-specific effects of drug treatment in complex tissues. This application requires high levels of precision, robustness, and quantitative accuracy-beyond those achievable with existing methods for mainly qualitative single-cell analysis. Here, we establish the use of standardized reference cells as spike-in controls for accurate and robust dissection of single-cell drug responses. RESULTS: We find that contamination by cell-free RNA can constitute up to 20% of reads in human primary tissue samples, and we show that the ensuing biases can be removed effectively using a novel bioinformatics algorithm. Applying our method to both human and mouse pancreatic islets treated ex vivo, we obtain an accurate and quantitative assessment of cell-specific drug effects on the transcriptome. We observe that FOXO inhibition induces dedifferentiation of both alpha and beta cells, while artemether treatment upregulates insulin and other beta cell marker genes in a subset of alpha cells. In beta cells, dedifferentiation and insulin repression upon artemether treatment occurs predominantly in mouse but not in human samples. CONCLUSIONS: This new method for quantitative, error-correcting, scRNA-seq data normalization using spike-in reference cells helps clarify complex cell-specific effects of pharmacological perturbations with single-cell resolution and high quantitative accuracy.
Source: Genome biology
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,990
Funders: European Molecular Biology Organization, Juvenile Diabetes Research Foundation United States of America, European Commission, Boehringer Ingelheim Fonds, Agence Nationale de la Recherche, Österreichischen Akademie der Wissenschaften, Austrian Science Fund, Bundesministerium für Digitalisierung und Wirtschaftsstandort, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, H2020 European Research Council
Awards: G1325952482, An experimental and bioinformatic toolbox for functional epigenomics and its application to epigenetically making and breaking a cancer cell, G15134332, Human Islet Distribution Coordinating Center, G195474297, G1961138394, Chromatin-localized central metabolism regulating gene expression and cell identity, Amplifying human beta cell differentiation using small molecules, G3669103487, G434337789, Deciphering the role of the transcription factor E2F1 in pancreatic beta-cell identity and plasticity, Monarchies and Hierarchies in Shaping Chromatin Landscapes, Myeloproliferative Neoplasms, Integrated Islet Distribution Program (U24) - 2021
OpenAlex ID: W3022232494
